May 2019

On April 23, 2019, the Manhattan U.S. Attorney and N.Y. Division of the Drug Enforcement Administration announced the “first ever…

On March 28, 2019, the Federal Trade Commission (“FTC”) issued an Opinion and Final Order against Impax Laboratories LLC…

On April 25, 2019,  Astellas Pharma US Inc. (“Astellas”) and Amgen Inc. (“Amgen”) agreed to pay a combined $125.75 million to…